Gout CKD Relationship — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Serial serum urate and renal function with dose titration to target
The best answer is “Serial serum urate and renal function with dose titration to target”. Chronic kidney disease affects drug choice and dosing, while serum urate demonstrates treat-to-target efficacy; renal function and adverse effects require monitoring without implying that urate lowering itself reverses CKD. The remaining choices—“Annual rheumatoid-factor measurement, after safety review, within a rheumatology pathway”, “Monthly plain radiographs of affected joints, after safety review”, “Routine renal biopsy before every dose increase, after specialist assessment”, “Urine microscopy as the sole efficacy measure, with clinical reassessment”—are credible in related rheumatology presentations, but each addresses a different diagnosis, investigation, treatment sequence or complication and does not fit the decisive findings in this stem.
Reference: NICE NG219 gout: https://www.nice.org.uk/guidance/ng219/chapter/Recommendations